Impact of Gene Polymorphisms on Clinical Outcome for Stage IV ...

Polymorphisms of the Dopamine D4 Receptor, Clinical Outcome ...

Inclusion of the effects of polymorphisms in the DRD1 and DAT1 genes allowed us both to test for additive genetic effects and to assess the specificity of the ...

Impacts of Genetic Polymorphisms on Breast Cancer

The Gly322Asp polymorphism affected the tumor grade and size, as well as was associated with the lymph node status. As literature data demonstrate DNA damages ...

Impact of CTLA4 genotype and other immune response gene ...

Significance of CTLA-4 and CD14 genetic polymorphisms in clinical outcome after allogeneic stem cell transplantation . Bone Marrow Transplant . 2007. ;. 40.

Application of gene polymorphisms to predict the sensitivity of ...

cant correlation of XRCC1 gene polymorphisms with age, gender, smoking status, pathological type, clinical stage ... As shown in Table 4, the effect of XRCC1 gene.

Influence of GST Gene Polymorphisms on the Clearance of ...

In conclusion, a pharmacogenetic approach using GST gene polymorphisms may be valuable in optimizing the i.v. busulfan dosage scheme. Our results also highlight ...

EP16.03-045 The Effect of Vascular Endothelial Growth Factor Gene ...

The Effect of Vascular Endothelial Growth Factor. Gene Polymorphisms in the Clinical Outcome of. Patients with Lung Cancer. Y. El Founini,1,2 F. Guessous,3,4 S.

Understanding Role of DNA Repair and Cytochrome p-450 Gene ...

Results: Patients with TA/AA genotype of CYP2E1 T>A polymorphism showed significantly poor response while those with GC/CC genotype of RAD51 G>C ...

Polymorphisms in DNA repair pathway genes and ABCG2 gene in

... impact on clinical outcomes. These data showed evidence by the ... grade 3, clinical stage IV, and lymph node-positive status. As to ...

Gene polymorphisms are associated with clinical outcome in ...

1. G/A. Abbreviations: SNP, Single-nucleotide polymorphism. Table 4: Genetic polymorphisms and prognosis analysis ... 170 laryngeal carcinoma (stages I to IV) ...

Cancer Research and Treatment

This study identified new polymorphisms in TYMS gene significantly associated with CAP-HFS, which may serve as useful genetic predictors for CAP-HFS and help to ...

(PDF) The impact of DNA damage response gene polymorphisms ...

patients'clinical outcome, overall survival (OS) and progression free survival (PFS). Results. Patient's characteristics. 240 patients with stage III/IV ...

Chronic Kidney Disease (CKD) - Medscape Reference

Patients with CKD stages 1-3 are generally asymptomatic. Typically, it is not until stages 4-5 (GFR < 30 mL/min/1.73 m²) that endocrine/ ...

Lacosamide Pharmacokinetics and Retention in Japanese Patients ...

... gene–dose effects of CYP2C19 polymorphisms between pediatric and adult patients. ... patients with severe CKD (stages 4–5), and changes in ...

American Journal of Obstetrics & Gynecology: Home Page

2023 Impact Factor. 8.8. 2023 5-Year Impact Factor. 14.3. 2023 CiteScore ... stages, intra-partum ultrasound, post-partum hemorrhage, clinical chorioamnionitis.

Biotechnology - Wikipedia

Biotechnology had a significant impact on many areas of society, from medicine to agriculture to environmental science. One of the key techniques used in ...

Journal of Dairy Science: Home Page

2023 Impact Factor. 4.1. 2023 5-Year Impact Factor. 6.2. CiteScore. Rank 6/63. Agriculture, Dairy and Animal Science. Rank 40/144. Food Science and Technology.

Volume 6, Number 5—October 2000 - Emerging Infectious Diseases ...

Host profiling might also identify gene expression signatures unique for each pathogen, thus providing a novel tool for diagnosis, prognosis, and clinical ...

Supporting researchers | World Cancer Research Fund

Our Academy Fellows are scientific or policy professionals at various stages of their career with a research interest in the field of cancer ...

Systemic Lupus Erythematosus (SLE) - Medscape Reference

Clinical features tend to vary between children and adults with SLE: signs including malar rash, seizures, and fever are more common in children ...

PharmGKB

PharmGKB is a comprehensive resource that curates knowledge about the impact of genetic variation on drug response for clinicians and researchers.